Anavex Life Sciences Corp (AVXL)

[tradeherpete]

Here's some of transcription I did for the Cowan presentation.

Slide 5 PDD 14 week study.
Enrollment is doing extremely well, now over 50%.
Just received a request from the Investigators to consider planning an extension for these patients which we are planning to do so.

The P-2a AD study which is now an extension study of the initial 32 patients and lasting now 208 weeks, which was initially a PK study lasting for 5 weeks and then has been extended thereafter in multiple occasions now reaching full 5 year, over 5 year period of observing safety and also exploratory efficacy.

I’d like to also mention that we have sufficient cash including non dilutive grants and governmental third parties to fund all the objectives for the next two years.